EAU 2020: Case-based Debate PSMA-targeted Radioligand Therapy: Which Patients, Which Stages? Treatment Options: Medical oncologist, Nuclear medicine, and Urologist Perspectives

(UroToday.com) In this interesting debate, Dr. Tsaur presented a case of a 63-year-old man who initially underwent robotic radical prostatectomy with pathology showing a pT3bN0M0 Gleason 7 disease with an initial PSA of 18 ng/ml.